CLARENCE, N.Y.–(BUSINESS WIRE)–Greatbatch, Inc. (NYSE:GB – News), today announced results for its third quarter ended October 2, 2009:
* CRM/Neuromodulation revenue growth of 5%
* Orthopaedic and Electrochem revenue negatively impacted by market slowdown
* GAAP operating results include impact of $34.5 million Electrochem litigation charge
* Cash flows from operations of $29 million
* Consolidation initiatives remain on track
* Annual operating margin guidance maintained on reduced full year revenue expectations
